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Abstract: Herpes zoster (HZ) is a secondary manifestation of a primary infection with varicella-zoster virus (VZV). HZ is 
caused by reactivation of VZV in the cranial nerves and dorsal spinal root ganglia. VZV, a human herpes virus (HHV3 - 
Human Herpes Virus 3) has a double-stranded linear DNA molecule (Wolff, 1999), has a bilayer lipid shell with surface 
glycoproteins and an icosahedral capsid. When VZV-specific cellular immunity is impaired, the onset of the disease occurs. 
A number of therapeutic approaches were available, showing little evidence of effectiveness. However, some therapies 
seems to be more effective, decreasing the extent and time duration of symptoms and, putatively, the risk of chronic 
sequelae [e.g. Post-herpetic neuralgia (NPH)]. Ozone has been shown to have an antibacterial and antiviral effect. 
Antiviral chemotherapy is based on acyclovir, valacyclovir or famcyclovir, with or without prednisolone, but they have 
little effect on the healing of skin lesions or pain (Wood, Johnson, McKendrick, Taylor, Mandal & Crooks, 1994). Most viruses 
coated by a lipid envelope in aqueous media are more sensitive to ozone, given their oxidant capacity over glycoproteins 
and lipoproteins (Wells, Latino, Gavalchin & Poiesz, 1991), however, virucidal activity becomes uncertain when viruses are 
in biological fluids or are intracellular. Effectiveness of ozone therapy through injections of the oxygen-ozone mixture has 
showned (vg. Konrad, 1995; Petry, Rossato, Nespolo, Kreutz, & Bertol, 2014) and topical applications of ozonated sunflower 
oil as well (Matsumoto, Sakurai, Shinriki, Suzuki & Miura, 2001).  We report a case study of a patient with cutaneous 
manifestations of HZ, with improvement of the clinical feature after therapy with ozone. 
A 70-year-old caucasian female patient was referred to the clinic with a history of pruritus, burn sensation, sharp pain in 
the lumbar region and left flank. Physical examination of the skin showed a dermatological eruption, with pustules, 
ulceration and crusting, in the affected region. The patient also found numbness and tingling in the same place. These 
symptoms were accompanied by fatigue. The patient reported a history of VZV infection during childhood. The therapeutic 
procedure to be applied, initiated after informed consent of the patient, was presented. The possibility of voluntary 
interruption was assured, as well as the report of any clinical manifestation concomitant with the therapeutic procedure 
was advised. The therapeutic protocol consisted of the following: daily intake of 20 mL of ozonated olea europea and 
helianthus annuus in ampoules and topical application of ozonized oil (olea europea and helianthus annuus), with 
previous hygiene through an ozonized soap. No viral chemotherapy performed or administration of non-steroidal anti-
inflammatory drugs. 
The administration of ozone seems to accelerate the healing of cutaneous lesions, limiting the severity and acute pain. 
During the therapeutic intervention a pigmentation alteration (post-inflammatory) was observed along the affected 
dermatome. Since ozone promotes the oxidation of viral components, a favorable therapeutic result was obtained by oral 
administration of ampules, without resorting to an invasive procedure - injection of an ozone-oxygen mixture. The results 
obtained in this patient are encouraging for future clinical trials, double blind, and eventually with placebo groups and of 
drugs already tested for effectiveness evaluation. 
 
Keywords: Herpes zoster, ozone therapy, therapeutic indications 
 
References 
Konrad, H. (1995). Ozone therapy for herpes simplex and herpes zoster, in Proceedings Ozone in Medicine, 12th World Congress of the 
International Ozone Association, 15th to 18th May 1995, Lille, France (International Ozone Association, Ed.), Instaprint S.A., Tours, pp.187-
194. 
Matsumoto, A., Sakurai S., Shinriki N., Suzuki S., and Miura T. (2001). Therapeutic effects of ozonized olive oil in the treatment of intractable 
fistula and wound after surgical operation, in Proceedings of the 15th Ozone World Congress, London, UK, 11th-15th September 2001, 
Medical Therapy Conference (IOA 2001, Ed.), Speedprint MacMedia Ltd, Ealing, London, UK, pp.77-84. 
Petry, G., Rossato, L.G., Nespolo, J., Kreutz, L.C. and Bertol, C.D. (2014). In Vitro Inactivation of Herpes Virus by Ozone. The Journal of the 
International Ozone Association, 36, 249-252 
Wells, K. H., Latino J., Gavalchin J., and Poiesz B. J. (1991). Inactivation of human immunodeficiency virus type 1 by ozone in vitro. Blood. 78:1882-
1890. 
Wolff, M. H. (1999). Varicella-Zoster Virus: Molecular Biology, Pathogenesis, and Clinical Aspects. Karger Publishers, pp. 1-2. 
Wood, M. J., Johnson R. W., McKendrick M. W., Taylor J., Mandal B. K., and Crooks J. (1994). A randomized trial of acyclovir for 7 days or 21 days 
with and without prednisolone for treatment of acute herpes zoster. New England Journal of Medicine, 330, 896-900. 
Citação: 
Ladera, V., Sargento, P., Perea, V., Faria, M., Teixeira, M., & Garcia, R. (2017). Pereira, J., Sargento, P., Faria, M., & Teixeira, M. (2017). Ozone 
Therapy for Herpes Zoster: case report. In Ribeiro, J. & Lima, E. (eds). Atas do II Encontro Nacional de Novos Investigadores em Saúde & II 
International Meeting of New Health Researchers. Leiria: Politécnico de Leiria. p. 39 
